Skip to main content

Table 3 Blood pressures and laboratory findings of metabolic syndrome

From: Impact of very preterm birth and post-discharge growth on cardiometabolic outcomes at school age: a retrospective cohort study

  VP/VLBW (n = 60) Term (n = 110) p-value
Systolic BP (mmHg) 107 (102.5–111.0) 97.5 (93.0-102.0) < 0.001
Diastolic BP (mmHg) 64 (59.3–68.5) 59 (54.5–64.0) < 0.001
HDL-Cholesterol (mg/dL) 69 (61–79) 64 (55–73) 0.010
TG (mg/dL) 60 (46–74) 57.5 (48–74) 0.844
Fasting glucose (mg/dL) 96 (93–101) 93 (88–97) < 0.001
Fasting insulin (µIU/mL) 4.4 (3.4–5.9) 3.7 (2.6–5.8) 0.053
HOMA-IR 1.1 (0.81–1.49) 0.8 (0.58–1.35) 0.017
Leptin (ng/mL) 6.4 (5.1–10.0) 5.8 (4.0-9.3) 0.040
Adiponectin (µg/mL) 9.7 (7.2–11.5) 8.9 (6.6–10.9) 0.297
  1. Values are expressed as the median (interquartile range). The Wilcoxon rank sum test was used for the comparison of continuous variables, and Fisher’s exact test was used for categorical variables
  2. VP/VLBW very preterm/very low birthweight, BP blood pressure. HDL-Cholesterol high-density lipoprotein cholesterol, TG triglyceride, HOMA-IR homeostasis model assessment of insulin resistance